EP3444274
Stöðug og leysanleg mótefni sem hindra TNF
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.6.2009EP published:
23.12.2020EP application number:
18177227.8
EP translation filed:
5.3.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
24.6.2029Expiry date:
24.6.2026Next due date:
30.6.2026
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF
Timeline
Today
25.6.2009EP application
23.12.2020EP Publication
5.3.2021Translation submitted
15.3.2021Registration published
24.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Borras, LeonardoAddress:
8952 Schlieren, CH
Name:
Gunde, TeaAddress:
8005 Zürich, CH
Name:
Urech, DavidAddress:
8645 Jona, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
75640 PDate:
25.6.2008Country:
US
Number:
75692 PDate:
25.6.2008Country:
US
Number:
75697 PDate:
25.6.2008Country:
US
Number:
75956 PDate:
26.6.2008Country:
US
Number:
155041 PDate:
24.2.2009Country:
US
Classification
Categories:
C07K 16/24, A61K 39/395, C12N 15/13
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 21.5.2021
Expires: 24.6.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2022
Expires: 24.6.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.